Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-heteroaryl indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof

N-heteroaryl indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof

US Patent 12030872 · Granted Jul 9, 2024

Estimated economic value: $173,599,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dumbbell capable of adjusting weight rapidly, and dumbbell assembly2025
Lipidated peptide inhibitors of interleukin-23 receptor2025
Natriuretic peptide receptor a agonists useful for the treatment of cardiometabo2025
WRN inhibitors2025
Recombinant oncolytic virus composition and use thereof2025
WRN inhibitors2025
SHP2 phosphatase inhibitors and methods of use thereof2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharm2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharm2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharm2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharm2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharm2025